GENE THERAPEUTIC APPROACH FOR TOLERANCE INDUCTION
$232,907R01FY2000AINIH
American National Red Cross, Washington DC
Investigators
Linked publications & trials
Paper 29857928Paper 24762281Paper 23729499Paper 23725600Paper 22936664Paper 22511718Paper 22394178Paper 22055221Paper 21811487Paper 21546313Paper 20955157Paper 20579844Paper 20536991Paper 20485267Paper 19995750Paper 18606668Paper 16860296Paper 16620748Paper 16219491Paper 16098495Paper 16002674Paper 15093551Paper 12096035Paper 11971030Paper 11067919Paper 11009088Paper 10903340
Abstract
DESCRIPTION (Adapted from the Investigator's abstract): This is an application to study tolerance induction by a peptide (12-26) epitope of a bacteriophage lambda protein fused at the N-terminus of an IgG heavy chain. Injection of the myeloma fusion protein or transduction of bone marrow cells with the gene for this fusion protein have both led to B-cell unresponsiveness in vivo. The investigators suggest that this system offers a novel approach for immunotherapy of autoimmune diseases.
View original record on NIH RePORTER →